Search This Site
 
     
  PRACTICE AREAS  
  View: Condensed Listing | Expanded Listing  
     
   
     
  FROM OUR BLOG  
 

INSULIN PUMP PROBLEMS CONTINUE TO PLAGUE DIABETICS

OFF-LABEL PROMOTION CONTINUES TO MAKE NEWS

HOSPITAL-ACQUIRED INFECTIONS STILL A HUGE THREAT TO PATIENTS

Step Therapy ? Health Care Cost Effectiveness at What Cost

More illegal off-label marketing? Fentora now under investigation

 
     
 
 

Oral Sodium Phosphates (Visicol, OsmoPrep and Phospho-soda) & Kidney damage

Before having a colonoscopy, patients have to go through the process of flushing out their bowels. However, new information indicating that this may be the most dangerous part of the procedure, as the drugs products that assist in the flushing may pose a risk of acute kidney injury.

The Food and Drug Administration has mandated Salix Pharmaceuticals Ltd., the manufacturer of two of the most commonly used prescription flushing products, Visicol and OsmoPrep, to put a "black box" warning on its labels. A "black box" warning is the most severe warning that the FDA issues on prescription medications. The agency further directed the drug manufacturer to conduct a clinical trial to specifically assess the risk of the products, especially to the kidneys.

The most vulnerable populations of patients to such effects on the kidneys are those older than 55; those who already suffer from dehydration, kidney disease, acute colitis or delayed bowel emptying; and those people taking other medicines that affect kidney function.

Dehydrated patients taking such medication have always been a concern, which is why even the current label suggests drinking a half-gallon of water when ingesting the drugs. Dehydration already affects kidney functions, so the combination of dehydration and these medications can be extremely dangerous.

The FDA also indicated that similar over-the-counter products, such as Fleet Phospho-soda, could have the same risks. Patients should only take such OTC medications in consultation with their physicians, and in fact, the FDA cautions consumers against using OTC cleansing products at all until further research is completed.

If you or a loved one were taking Visicol, OsmoPrep, or a similar drug and have since been diagnosed with kidney problems, contact the attorneys at Pogust Braslow & Millrood,  where Protecting Consumers Is Our Primary Goal. We will evaluate your case, explain all of your options, and work to assure that the appropriate parties are held responsible. Just fill out this form, click here to send us an email or call us at (610) 941-4204.

Contact Form
Name *
* denotes required fields
Address
 
City
State
Phone *
Email *
Your Question/Message *
* By typing "agree" into the below box you are confirming that you wish to send your information to Pogust Braslow & Millrood LLC.
  

 
 
Follow us on: Facebook Twitter
© 2010 Pogust Braslow & Millrood LLC. All rights reserved.     Home  |  About Us  |  Contact Us  |  Disclaimer  |  Sitemap
Attorney Advertising
Website by Legal Internet Solutions Incorporated.